Brand Insights - Thought Leadership | Paid Program | Veradigm
Contrasting the view of heart failure patients as seen from the perspectives of two large but distinct sources of real-world data: the Veradigm Cardiology Registry and Practice Fusion
Advertisement
Advertisement
Trending on PharmExec
1
Pharmaceutical Executive Daily: CSL & Alentis Enter $1.6 Billion Global Partnership
2
Roundup: CSL & Alentis Enter Global Partnership, Jiangsu Nhwa Enters Global Licensing Deal with Somnivera
3
Roundup: Novartis & Abogen Enter Licensing and Option Agreement, AstraZeneca and Daiichi Sankyo Enter Clinical Collaboration with Summit Therapeutics
4
The Most Surprising Development in GLP-1s
5